Artificial Intelligence | Machine Learning | Natural Language Processing Causaly | Biomedical Research Discovery Tool


Enterprise, Research, Pharmaceutical, Semantic Search, Life Sciences, Biomedical Information London, England, United Kingdom

Causaly

Artificial Intelligence | Machine Learning | Natural Language Processing


Causaly | Biomedical Research Discovery Tool

Causaly

Research, Pharmaceutical, Semantic Search, Life Sciences, Biomedical Information


London, England, United Kingdom

Causaly AI finds hidden evidence in the world’s biomedical literature. Our mission is to transform how humans can find, visualise and interpret biomedical knowledge, and contribute to accelerating solutions to some of the greatest challenges we face. Our platform understands evidence by semantics and temporal occurrence, and machine-reads all published evidence to date, identifying all known cause and effect relationships, rapidly accelerating life science research and discovery. Current applications include drug discovery, toxicology, safety, epidemiology, due diligence, drug commercialisation, market access, clinical care and more.

Causaly is an AI for Biomedical Cause & Effect discovery, empowering researchers and decision makers to quickly find causal evidence and generate insights from vast amounts of documents. The company is developing a machine-reading platform that turns free-flow text into causal knowledge graphs and applies machine learning to surface new knowledge. This helps users to accelerate their research schedules and improve time-to-insight significantly.

 
 

   Total Funding: $6,000,000

   Funding Stage: Series A

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 26 to 50

   Founded: 2017

 
 

Date

Round

$ Raised

Investors

07/13/2023

Series B

$60M

ICONIQ Growth, Index Ventures, Marathon Ventures, EBRD, Pentech Ventures

Date : 07/13/2023

Round: Series B

$ Raised: $60M

Investors: ICONIQ Growth, Index Ventures, Marathon Ventures, EBRD, Pentech Ventures

05/17/2021

Series A

$17M

Pentech, Panos Papadopoulos, Index Ventures, EBRD

Date : 05/17/2021

Round: Series A

$ Raised: $17M

Investors: Pentech, Panos Papadopoulos, Index Ventures, EBRD

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Causaly

 
 
 
Yiannis Kiachopoulos


Yiannis Kiachopoulos
Co-founder, CEO

Artur Saudabayev


Artur Saudabayev
Co-Founder, CTO

 
 

Causaly is growing. Want to work at Causaly? Causaly is hiring. Join team at Causaly

 

View All

Software Engineer, Javascript

Athens, Athens

Science Liaison (Biomedicine)

Athens, Athens

Data Quality Analyst

Athens, Athens

Product Owner

Athens, Athens

Financial Controller/ Administator

Athens, Athens

 
 
appengine.ai

World's Most Promising AI/ML Startups